Townson Sharon sold GLUE
June 23, 2026 · Form 4 insider transaction
Townson Sharon sold 3,000 shares of Monte Rosa Therapeutics, Inc. at $20.00 per share, a transaction worth $60.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
3,000
Price
$20.00
Total value
$60.0K
InsiderTownson Sharon
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 23, 2026
Filing dateJune 25, 2026
Shares owned after67,845
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2026.